Shore Capital, which has a price target of 2200p, called the ruling another ray of light for the drugs firm on Zantac. It added ... in a session when bottling firm Coca-Cola HBC topped the blue-chip ...

Shore Capital, which has a price target of 2200p, called the ruling another ray of light for the drugs firm on Zantac ... firm Coca-Cola HBC topped the blue-chip index with a gain of 40.5p ...

On Wednesday, a jury in Cook County Circuit Court in Illinois ended in a mistrial in a case against Zantac manufacturer Boehringer Ingelheim, the second in the past two months. Another jury in the ...

Hung jury in latest Zantac cancer trial in Chicago Boehringer Ingelheim only defendant after settlements with GSK, Pfizer FDA pulled Zantac in 2020 over NDMA carcinogen concerns Sept 18 (Reuters ...

(Reuters) - The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with a hung jury on Wednesday, as jurors in Chicago were unable to agree on whether ...

A Chicago jury failed to reach a verdict Sept. 18 over claims that heartburn drug Zantac causes cancer, Reuters exclusively reported. The case, brought by Illinois resident Ronald Kimbrow ...

Boehringer Ingelheim Faces Second Hung Jury in Chicago Zantac Trial By Brendan Pierson (Reuters) -The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with ...

(RTTNews) - Drug maker GSK plc (GSK, GSK.L) confirmed Wednesday that it has reached two confidential settlements in cases filed in California State Court against heartburn drug Zantac (ranitidine ...

(Reuters) - British drugmaker GSK said on Wednesday it had agreed to settle two lawsuits in California that claimed its discontinued heartburn drug Zantac caused cancer. GSK does not admit to any ...